Back to Search Start Over

Cracking the tough ones

Authors :
Mullin, Rick
Source :
Chemical & Engineering News. Feb 22, 2010, Vol. 88 Issue 8, p12, 7 p.
Publication Year :
2010

Abstract

Pharmaceutical firms are forming partnerships to seek evasive cures, as seen in GlaxoSmithKline PLC and Pfizer Inc.'s ViiV venture on HIV/AIDS drugs. Wyeth has also formed a research venture with Janssen Alzheimer Immunotherapy Research & Development on Alzheimer's disease therapy. Details on other partnerships are presented.

Details

Language :
English
ISSN :
00092347
Volume :
88
Issue :
8
Database :
Gale General OneFile
Journal :
Chemical & Engineering News
Publication Type :
Periodical
Accession number :
edsgcl.221383430